当前位置: 首页 > 详情页

Reduction of Foxp3+T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China; [2]Capital Med Univ, Beijing Tiantan Hosp, Dept Hematol, Beijing, Peoples R China
出处:
ISSN:

关键词: hematopoietic stem cell transplantation chronic graft-versus-host disease regulatory T cells

摘要:
Foxp3+ T cells (CD4+ Tregs and CD8+ Treg) have been demonstrated to play roles in the maintenance of tolerance after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). We have found that Foxp3+ TCR+ Treg cells (Tregs) exerted regulatory functions. In the current study, patients were recruited and divided as non-cGVHD, limited cGVHD and extensive cGVHD groups. Healthy volunteers were recruited as healthy group. Treg cells were evaluated by flow cytometry. Serum cytokine levels of IL-2, tumour necrosis factor-, interferon- and transforming growth factor-1 (TGF-1) were evaluated by ELISA. The results showed that percentages of CD4+ Tregs, CD8+ Tregs and Tregs were all significantly increased in non-cGVHD group compared with those in healthy group, limited cGVHD group and extensive cGVHD group. Moreover, compared with extensive cGVHD group, percentages of these three types of Tregs were significantly increased in limited cGVHD group. The levels of TGF-1 increased dramatically in non-cGVHD group compared with other groups. Spearman's correlation analysis revealed that the increased levels of TGF-1 and IL-2 were positively associated with increased Treg subsets, indicating that TGF-1 and IL-2 participated in the expansion process of Foxp3+ Tregs in vivo. Our findings support that increasing the number of Tregs following allo-HSCT would be a preferential strategy for controlling cGVHD. Copyright (c) 2015 John Wiley & Sons, Ltd.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 血液学 3 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 血液学 4 区 肿瘤学
JCR分区:
出版当年[2015]版:
Q2 ONCOLOGY Q2 HEMATOLOGY
最新[2023]版:
Q2 HEMATOLOGY Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China;
通讯作者:
通讯机构: [1]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院